Global Endocannabinoid System Targeted Therapeutics Market Research Report 2025(Status and Outlook)
Report Overview
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
The global Endocannabinoid System Targeted Therapeutics market size was estimated at USD 485.2 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Endocannabinoid System Targeted Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Endocannabinoid System Targeted Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Endocannabinoid System Targeted Therapeutics market
Global Endocannabinoid System Targeted Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Market Segmentation (by Type)
Oral
Inhalation
Others
Market Segmentation (by Application)
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endocannabinoid System Targeted Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Endocannabinoid System Targeted Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Endocannabinoid System Targeted Therapeutics refers to the use of the endocannabinoid system as a therapeutic target to treat some diseases
The global Endocannabinoid System Targeted Therapeutics market size was estimated at USD 485.2 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Endocannabinoid System Targeted Therapeutics market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Endocannabinoid System Targeted Therapeutics market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Endocannabinoid System Targeted Therapeutics market
Global Endocannabinoid System Targeted Therapeutics Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GW Pharmaceuticals
MAKScientific
Corbus Pharmaceuticals
Tilray
Pure Green
Avicanna
GB Sciences
Botanix Pharmaceuticals
Therapix Biosciences
Zelira Therapeutics
Market Segmentation (by Type)
Oral
Inhalation
Others
Market Segmentation (by Application)
Autoimmune Disorders
Genetic Disorders
Neurological Disorders
Pain Disorders
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Endocannabinoid System Targeted Therapeutics Market
- Overview of the regional outlook of the Endocannabinoid System Targeted Therapeutics Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Endocannabinoid System Targeted Therapeutics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Endocannabinoid System Targeted Therapeutics, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Endocannabinoid System Targeted Therapeutics
1.2 Key Market Segments
1.2.1 Endocannabinoid System Targeted Therapeutics Segment by Type
1.2.2 Endocannabinoid System Targeted Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Endocannabinoid System Targeted Therapeutics Product Life Cycle
3.3 Global Endocannabinoid System Targeted Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Endocannabinoid System Targeted Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Endocannabinoid System Targeted Therapeutics Market Competitive Situation and Trends
3.8.1 Endocannabinoid System Targeted Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Endocannabinoid System Targeted Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Endocannabinoid System Targeted Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Endocannabinoid System Targeted Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Endocannabinoid System Targeted Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Endocannabinoid System Targeted Therapeutics Price by Type (2020-2025)
7 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endocannabinoid System Targeted Therapeutics Market Sales by Application (2020-2025)
7.3 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2020-2025)
8 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SALES BY REGION
8.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region
8.2 Global Endocannabinoid System Targeted Therapeutics Market Size by Region
8.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size by Region
8.2.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Endocannabinoid System Targeted Therapeutics Sales by Country
8.3.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Endocannabinoid System Targeted Therapeutics Sales by Country
8.4.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region
8.5.2 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Endocannabinoid System Targeted Therapeutics Sales by Country
8.6.2 South America Endocannabinoid System Targeted Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region
8.7.2 Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Endocannabinoid System Targeted Therapeutics by Region(2020-2025)
9.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Endocannabinoid System Targeted Therapeutics Production
9.4.1 North America Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Endocannabinoid System Targeted Therapeutics Production
9.5.1 Europe Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Endocannabinoid System Targeted Therapeutics Production (2020-2025)
9.6.1 Japan Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Endocannabinoid System Targeted Therapeutics Production (2020-2025)
9.7.1 China Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GW Pharmaceuticals
10.1.1 GW Pharmaceuticals Basic Information
10.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
10.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
10.1.4 GW Pharmaceuticals Business Overview
10.1.5 GW Pharmaceuticals SWOT Analysis
10.1.6 GW Pharmaceuticals Recent Developments
10.2 MAKScientific
10.2.1 MAKScientific Basic Information
10.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
10.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Product Market Performance
10.2.4 MAKScientific Business Overview
10.2.5 MAKScientific SWOT Analysis
10.2.6 MAKScientific Recent Developments
10.3 Corbus Pharmaceuticals
10.3.1 Corbus Pharmaceuticals Basic Information
10.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
10.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
10.3.4 Corbus Pharmaceuticals Business Overview
10.3.5 Corbus Pharmaceuticals SWOT Analysis
10.3.6 Corbus Pharmaceuticals Recent Developments
10.4 Tilray
10.4.1 Tilray Basic Information
10.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Overview
10.4.3 Tilray Endocannabinoid System Targeted Therapeutics Product Market Performance
10.4.4 Tilray Business Overview
10.4.5 Tilray Recent Developments
10.5 Pure Green
10.5.1 Pure Green Basic Information
10.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
10.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Product Market Performance
10.5.4 Pure Green Business Overview
10.5.5 Pure Green Recent Developments
10.6 Avicanna
10.6.1 Avicanna Basic Information
10.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
10.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Product Market Performance
10.6.4 Avicanna Business Overview
10.6.5 Avicanna Recent Developments
10.7 GB Sciences
10.7.1 GB Sciences Basic Information
10.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
10.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Product Market Performance
10.7.4 GB Sciences Business Overview
10.7.5 GB Sciences Recent Developments
10.8 Botanix Pharmaceuticals
10.8.1 Botanix Pharmaceuticals Basic Information
10.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
10.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
10.8.4 Botanix Pharmaceuticals Business Overview
10.8.5 Botanix Pharmaceuticals Recent Developments
10.9 Therapix Biosciences
10.9.1 Therapix Biosciences Basic Information
10.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
10.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Market Performance
10.9.4 Therapix Biosciences Business Overview
10.9.5 Therapix Biosciences Recent Developments
10.10 Zelira Therapeutics
10.10.1 Zelira Therapeutics Basic Information
10.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
10.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Market Performance
10.10.4 Zelira Therapeutics Business Overview
10.10.5 Zelira Therapeutics Recent Developments
11 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast
11.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region
11.2.4 South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Endocannabinoid System Targeted Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Endocannabinoid System Targeted Therapeutics by Type (2026-2033)
12.1.2 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Endocannabinoid System Targeted Therapeutics by Type (2026-2033)
12.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Endocannabinoid System Targeted Therapeutics
1.2 Key Market Segments
1.2.1 Endocannabinoid System Targeted Therapeutics Segment by Type
1.2.2 Endocannabinoid System Targeted Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Endocannabinoid System Targeted Therapeutics Product Life Cycle
3.3 Global Endocannabinoid System Targeted Therapeutics Sales by Manufacturers (2020-2025)
3.4 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Manufacturers (2020-2025)
3.5 Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Endocannabinoid System Targeted Therapeutics Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Endocannabinoid System Targeted Therapeutics Market Competitive Situation and Trends
3.8.1 Endocannabinoid System Targeted Therapeutics Market Concentration Rate
3.8.2 Global 5 and 10 Largest Endocannabinoid System Targeted Therapeutics Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS INDUSTRY CHAIN ANALYSIS
4.1 Endocannabinoid System Targeted Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Endocannabinoid System Targeted Therapeutics Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Endocannabinoid System Targeted Therapeutics Market
5.7 ESG Ratings of Leading Companies
6 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2020-2025)
6.3 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Type (2020-2025)
6.4 Global Endocannabinoid System Targeted Therapeutics Price by Type (2020-2025)
7 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Endocannabinoid System Targeted Therapeutics Market Sales by Application (2020-2025)
7.3 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Application (2020-2025)
7.4 Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2020-2025)
8 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET SALES BY REGION
8.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.1 Global Endocannabinoid System Targeted Therapeutics Sales by Region
8.1.2 Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region
8.2 Global Endocannabinoid System Targeted Therapeutics Market Size by Region
8.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size by Region
8.2.2 Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region
8.3 North America
8.3.1 North America Endocannabinoid System Targeted Therapeutics Sales by Country
8.3.2 North America Endocannabinoid System Targeted Therapeutics Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Endocannabinoid System Targeted Therapeutics Sales by Country
8.4.2 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region
8.5.2 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Endocannabinoid System Targeted Therapeutics Sales by Country
8.6.2 South America Endocannabinoid System Targeted Therapeutics Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region
8.7.2 Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET PRODUCTION BY REGION
9.1 Global Production of Endocannabinoid System Targeted Therapeutics by Region(2020-2025)
9.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Region (2020-2025)
9.3 Global Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Endocannabinoid System Targeted Therapeutics Production
9.4.1 North America Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.4.2 North America Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Endocannabinoid System Targeted Therapeutics Production
9.5.1 Europe Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.5.2 Europe Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Endocannabinoid System Targeted Therapeutics Production (2020-2025)
9.6.1 Japan Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.6.2 Japan Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Endocannabinoid System Targeted Therapeutics Production (2020-2025)
9.7.1 China Endocannabinoid System Targeted Therapeutics Production Growth Rate (2020-2025)
9.7.2 China Endocannabinoid System Targeted Therapeutics Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GW Pharmaceuticals
10.1.1 GW Pharmaceuticals Basic Information
10.1.2 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
10.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
10.1.4 GW Pharmaceuticals Business Overview
10.1.5 GW Pharmaceuticals SWOT Analysis
10.1.6 GW Pharmaceuticals Recent Developments
10.2 MAKScientific
10.2.1 MAKScientific Basic Information
10.2.2 MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
10.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Product Market Performance
10.2.4 MAKScientific Business Overview
10.2.5 MAKScientific SWOT Analysis
10.2.6 MAKScientific Recent Developments
10.3 Corbus Pharmaceuticals
10.3.1 Corbus Pharmaceuticals Basic Information
10.3.2 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
10.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
10.3.4 Corbus Pharmaceuticals Business Overview
10.3.5 Corbus Pharmaceuticals SWOT Analysis
10.3.6 Corbus Pharmaceuticals Recent Developments
10.4 Tilray
10.4.1 Tilray Basic Information
10.4.2 Tilray Endocannabinoid System Targeted Therapeutics Product Overview
10.4.3 Tilray Endocannabinoid System Targeted Therapeutics Product Market Performance
10.4.4 Tilray Business Overview
10.4.5 Tilray Recent Developments
10.5 Pure Green
10.5.1 Pure Green Basic Information
10.5.2 Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
10.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Product Market Performance
10.5.4 Pure Green Business Overview
10.5.5 Pure Green Recent Developments
10.6 Avicanna
10.6.1 Avicanna Basic Information
10.6.2 Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
10.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Product Market Performance
10.6.4 Avicanna Business Overview
10.6.5 Avicanna Recent Developments
10.7 GB Sciences
10.7.1 GB Sciences Basic Information
10.7.2 GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
10.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Product Market Performance
10.7.4 GB Sciences Business Overview
10.7.5 GB Sciences Recent Developments
10.8 Botanix Pharmaceuticals
10.8.1 Botanix Pharmaceuticals Basic Information
10.8.2 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
10.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Market Performance
10.8.4 Botanix Pharmaceuticals Business Overview
10.8.5 Botanix Pharmaceuticals Recent Developments
10.9 Therapix Biosciences
10.9.1 Therapix Biosciences Basic Information
10.9.2 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
10.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Market Performance
10.9.4 Therapix Biosciences Business Overview
10.9.5 Therapix Biosciences Recent Developments
10.10 Zelira Therapeutics
10.10.1 Zelira Therapeutics Basic Information
10.10.2 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
10.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Market Performance
10.10.4 Zelira Therapeutics Business Overview
10.10.5 Zelira Therapeutics Recent Developments
11 ENDOCANNABINOID SYSTEM TARGETED THERAPEUTICS MARKET FORECAST BY REGION
11.1 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast
11.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
11.2.3 Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region
11.2.4 South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Endocannabinoid System Targeted Therapeutics by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Endocannabinoid System Targeted Therapeutics by Type (2026-2033)
12.1.2 Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Endocannabinoid System Targeted Therapeutics by Type (2026-2033)
12.2 Global Endocannabinoid System Targeted Therapeutics Market Forecast by Application (2026-2033)
12.2.1 Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application
12.2.2 Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Endocannabinoid System Targeted Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Endocannabinoid System Targeted Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2024)
Table 10. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Endocannabinoid System Targeted Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Endocannabinoid System Targeted Therapeutics Sales by Type (K Units)
Table 26. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (M USD)
Table 27. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Type (2020-2025)
Table 28. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Endocannabinoid System Targeted Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Endocannabinoid System Targeted Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Application
Table 33. Global Endocannabinoid System Targeted Therapeutics Market Size by Application
Table 34. Global Endocannabinoid System Targeted Therapeutics Sales by Application (2020-2025) & (K Units)
Table 35. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2020-2025)
Table 38. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Endocannabinoid System Targeted Therapeutics Sales by Region (2020-2025) & (K Units)
Table 40. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Endocannabinoid System Targeted Therapeutics Sales by Country (2020-2025) & (K Units)
Table 44. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Endocannabinoid System Targeted Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Endocannabinoid System Targeted Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. South America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Endocannabinoid System Targeted Therapeutics Production (K Units) by Region(2020-2025)
Table 54. Global Endocannabinoid System Targeted Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. GW Pharmaceuticals Basic Information
Table 62. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 63. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. GW Pharmaceuticals Business Overview
Table 65. GW Pharmaceuticals SWOT Analysis
Table 66. GW Pharmaceuticals Recent Developments
Table 67. MAKScientific Basic Information
Table 68. MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
Table 69. MAKScientific Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. MAKScientific Business Overview
Table 71. MAKScientific SWOT Analysis
Table 72. MAKScientific Recent Developments
Table 73. Corbus Pharmaceuticals Basic Information
Table 74. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 75. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Corbus Pharmaceuticals Business Overview
Table 77. Corbus Pharmaceuticals SWOT Analysis
Table 78. Corbus Pharmaceuticals Recent Developments
Table 79. Tilray Basic Information
Table 80. Tilray Endocannabinoid System Targeted Therapeutics Product Overview
Table 81. Tilray Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Tilray Business Overview
Table 83. Tilray Recent Developments
Table 84. Pure Green Basic Information
Table 85. Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
Table 86. Pure Green Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Pure Green Business Overview
Table 88. Pure Green Recent Developments
Table 89. Avicanna Basic Information
Table 90. Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
Table 91. Avicanna Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Avicanna Business Overview
Table 93. Avicanna Recent Developments
Table 94. GB Sciences Basic Information
Table 95. GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 96. GB Sciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. GB Sciences Business Overview
Table 98. GB Sciences Recent Developments
Table 99. Botanix Pharmaceuticals Basic Information
Table 100. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 101. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Botanix Pharmaceuticals Business Overview
Table 103. Botanix Pharmaceuticals Recent Developments
Table 104. Therapix Biosciences Basic Information
Table 105. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 106. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Therapix Biosciences Business Overview
Table 108. Therapix Biosciences Recent Developments
Table 109. Zelira Therapeutics Basic Information
Table 110. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
Table 111. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Zelira Therapeutics Business Overview
Table 113. Zelira Therapeutics Recent Developments
Table 114. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Endocannabinoid System Targeted Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Endocannabinoid System Targeted Therapeutics Market Size Comparison by Region (M USD)
Table 5. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Endocannabinoid System Targeted Therapeutics Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2024)
Table 10. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Endocannabinoid System Targeted Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Endocannabinoid System Targeted Therapeutics Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Endocannabinoid System Targeted Therapeutics Sales by Type (K Units)
Table 26. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (M USD)
Table 27. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Type (2020-2025)
Table 28. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Type (2020-2025)
Table 29. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) by Type (2020-2025)
Table 30. Global Endocannabinoid System Targeted Therapeutics Market Size Share by Type (2020-2025)
Table 31. Global Endocannabinoid System Targeted Therapeutics Price (USD/Unit) by Type (2020-2025)
Table 32. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) by Application
Table 33. Global Endocannabinoid System Targeted Therapeutics Market Size by Application
Table 34. Global Endocannabinoid System Targeted Therapeutics Sales by Application (2020-2025) & (K Units)
Table 35. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2020-2025)
Table 36. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2020-2025) & (M USD)
Table 37. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2020-2025)
Table 38. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2020-2025)
Table 39. Global Endocannabinoid System Targeted Therapeutics Sales by Region (2020-2025) & (K Units)
Table 40. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2020-2025)
Table 41. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 42. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2020-2025)
Table 43. North America Endocannabinoid System Targeted Therapeutics Sales by Country (2020-2025) & (K Units)
Table 44. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Endocannabinoid System Targeted Therapeutics Sales by Country (2020-2025) & (K Units)
Table 46. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 49. South America Endocannabinoid System Targeted Therapeutics Sales by Country (2020-2025) & (K Units)
Table 50. South America Endocannabinoid System Targeted Therapeutics Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size by Region (2020-2025) & (M USD)
Table 53. Global Endocannabinoid System Targeted Therapeutics Production (K Units) by Region(2020-2025)
Table 54. Global Endocannabinoid System Targeted Therapeutics Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Region (2020-2025)
Table 56. Global Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Endocannabinoid System Targeted Therapeutics Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. GW Pharmaceuticals Basic Information
Table 62. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 63. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. GW Pharmaceuticals Business Overview
Table 65. GW Pharmaceuticals SWOT Analysis
Table 66. GW Pharmaceuticals Recent Developments
Table 67. MAKScientific Basic Information
Table 68. MAKScientific Endocannabinoid System Targeted Therapeutics Product Overview
Table 69. MAKScientific Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. MAKScientific Business Overview
Table 71. MAKScientific SWOT Analysis
Table 72. MAKScientific Recent Developments
Table 73. Corbus Pharmaceuticals Basic Information
Table 74. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 75. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Corbus Pharmaceuticals Business Overview
Table 77. Corbus Pharmaceuticals SWOT Analysis
Table 78. Corbus Pharmaceuticals Recent Developments
Table 79. Tilray Basic Information
Table 80. Tilray Endocannabinoid System Targeted Therapeutics Product Overview
Table 81. Tilray Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Tilray Business Overview
Table 83. Tilray Recent Developments
Table 84. Pure Green Basic Information
Table 85. Pure Green Endocannabinoid System Targeted Therapeutics Product Overview
Table 86. Pure Green Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Pure Green Business Overview
Table 88. Pure Green Recent Developments
Table 89. Avicanna Basic Information
Table 90. Avicanna Endocannabinoid System Targeted Therapeutics Product Overview
Table 91. Avicanna Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Avicanna Business Overview
Table 93. Avicanna Recent Developments
Table 94. GB Sciences Basic Information
Table 95. GB Sciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 96. GB Sciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. GB Sciences Business Overview
Table 98. GB Sciences Recent Developments
Table 99. Botanix Pharmaceuticals Basic Information
Table 100. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product Overview
Table 101. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Botanix Pharmaceuticals Business Overview
Table 103. Botanix Pharmaceuticals Recent Developments
Table 104. Therapix Biosciences Basic Information
Table 105. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product Overview
Table 106. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Therapix Biosciences Business Overview
Table 108. Therapix Biosciences Recent Developments
Table 109. Zelira Therapeutics Basic Information
Table 110. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product Overview
Table 111. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Zelira Therapeutics Business Overview
Table 113. Zelira Therapeutics Recent Developments
Table 114. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 115. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 116. North America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 117. North America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 118. Europe Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 119. Europe Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 120. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Forecast by Region (2026-2033) & (K Units)
Table 121. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Forecast by Region (2026-2033) & (M USD)
Table 122. South America Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (K Units)
Table 123. South America Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 124. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales Forecast by Country (2026-2033) & (Units)
Table 125. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size Forecast by Country (2026-2033) & (M USD)
Table 126. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Type (2026-2033) & (K Units)
Table 127. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Type (2026-2033) & (M USD)
Table 128. Global Endocannabinoid System Targeted Therapeutics Price Forecast by Type (2026-2033) & (USD/Unit)
Table 129. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) Forecast by Application (2026-2033)
Table 130. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Endocannabinoid System Targeted Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Endocannabinoid System Targeted Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Endocannabinoid System Targeted Therapeutics Product Life Cycle
Figure 13. Endocannabinoid System Targeted Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Endocannabinoid System Targeted Therapeutics
Figure 19. Global Endocannabinoid System Targeted Therapeutics Market PEST Analysis
Figure 20. Global Endocannabinoid System Targeted Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Endocannabinoid System Targeted Therapeutics Market Share by Type
Figure 27. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type in 2024
Figure 29. Market Size Share of Endocannabinoid System Targeted Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Endocannabinoid System Targeted Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Endocannabinoid System Targeted Therapeutics Market Share by Application
Figure 33. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Endocannabinoid System Targeted Therapeutics Market Share by Application in 2024
Figure 37. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Endocannabinoid System Targeted Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Endocannabinoid System Targeted Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Endocannabinoid System Targeted Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Endocannabinoid System Targeted Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Endocannabinoid System Targeted Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Endocannabinoid System Targeted Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Endocannabinoid System Targeted Therapeutics
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD), 2024-2033
Figure 5. Global Endocannabinoid System Targeted Therapeutics Market Size (M USD) (2020-2033)
Figure 6. Global Endocannabinoid System Targeted Therapeutics Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Endocannabinoid System Targeted Therapeutics Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Endocannabinoid System Targeted Therapeutics Product Life Cycle
Figure 13. Endocannabinoid System Targeted Therapeutics Sales Share by Manufacturers in 2024
Figure 14. Global Endocannabinoid System Targeted Therapeutics Revenue Share by Manufacturers in 2024
Figure 15. Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Endocannabinoid System Targeted Therapeutics Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2024
Figure 18. Industry Chain Map of Endocannabinoid System Targeted Therapeutics
Figure 19. Global Endocannabinoid System Targeted Therapeutics Market PEST Analysis
Figure 20. Global Endocannabinoid System Targeted Therapeutics Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Endocannabinoid System Targeted Therapeutics Market Share by Type
Figure 27. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type (2020-2025)
Figure 28. Sales Market Share of Endocannabinoid System Targeted Therapeutics by Type in 2024
Figure 29. Market Size Share of Endocannabinoid System Targeted Therapeutics by Type (2020-2025)
Figure 30. Market Size Share of Endocannabinoid System Targeted Therapeutics by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Endocannabinoid System Targeted Therapeutics Market Share by Application
Figure 33. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application (2020-2025)
Figure 34. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Application in 2024
Figure 35. Global Endocannabinoid System Targeted Therapeutics Market Share by Application (2020-2025)
Figure 36. Global Endocannabinoid System Targeted Therapeutics Market Share by Application in 2024
Figure 37. Global Endocannabinoid System Targeted Therapeutics Sales Growth Rate by Application (2020-2025)
Figure 38. Global Endocannabinoid System Targeted Therapeutics Sales Market Share by Region (2020-2025)
Figure 39. Global Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region (2020-2025)
Figure 40. North America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2024
Figure 43. North America Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2024
Figure 45. U.S. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Endocannabinoid System Targeted Therapeutics Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Endocannabinoid System Targeted Therapeutics Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Endocannabinoid System Targeted Therapeutics Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Endocannabinoid System Targeted Therapeutics Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2024
Figure 53. Europe Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2024
Figure 55. Germany Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2024
Figure 67. Asia Pacific Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2024
Figure 68. China Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 79. South America Endocannabinoid System Targeted Therapeutics Sales Market Share by Country in 2024
Figure 80. South America Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (M USD)
Figure 81. South America Endocannabinoid System Targeted Therapeutics Market Size Market Share by Country in 2024
Figure 82. Brazil Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Endocannabinoid System Targeted Therapeutics Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Endocannabinoid System Targeted Therapeutics Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Endocannabinoid System Targeted Therapeutics Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Endocannabinoid System Targeted Therapeutics Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Endocannabinoid System Targeted Therapeutics Production Market Share by Region (2020-2025)
Figure 103. North America Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 106. China Endocannabinoid System Targeted Therapeutics Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Endocannabinoid System Targeted Therapeutics Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Endocannabinoid System Targeted Therapeutics Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Type (2026-2033)
Figure 111. Global Endocannabinoid System Targeted Therapeutics Sales Forecast by Application (2026-2033)
Figure 112. Global Endocannabinoid System Targeted Therapeutics Market Share Forecast by Application (2026-2033)
